Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery

Stopped The study was terminated on the basis that protocol defined stopping criteria had been met.

Conditions

• Lung Injury, Acute and Respiratory Distress Syndrome, Adult

Interventions

• DRUG: GSK2862277
• DRUG: Placebo

Sponsor

GlaxoSmithKline